Company profile
Repron Therapeutics
Epigenetic silencing platform for tumor recurrence repression
- Industry
- Biotechnology Research
- Employees
- 1
- Headquarters
- Milan, Lombardy
- Founded
- 2023
- LinkedIn followers
- 347
- Office locations
- 1
Repron Therapeutics company summary
Repron Therapeutics is a company in the Biotechnology Research industry, headquartered in Milan, Lombardy, founded in 2023. On LinkedIn the company has around 1 employees and 347 followers. Its listed specialties include biotech and oncology.
What technology does Repron Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Repron Therapeutics
At Repron, we are developing an innovative strategy to inhibit the activity of oncogenes at the basis of tumor malignancy through the use of engineered synthetic factors. Oncogenic transcription factors activate thousands of target genes that, regulating processes like cell proliferation and invasiveness, make the cancer cells dangerous. By rational engineering of these factors, we exploit the natural binding ability to deliver repressive activity, instead of activation to their targets. Substituting the domain responsible for the activation with others featuring epigenetic inhibitory capabilities, we obtained Epigenetic Silencer Factors, that, once delivered in the cancer cells, are able to switch-off key genes for tumorigenesis. Our purpose is to provide solutions for those solid tumor cases in which the radical removal is not possible and metastasizing or recurrence is highly probable. Indeed, the delivery of Epigenetic Silencing Factors could intercept and eliminate either the remaining tumor cells at the primary site or the micro metastasis in target organs.
Specialties
Where is Repron Therapeutics located?
Repron Therapeutics lists 1 location.
Compare companies similar to Repron Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Repron Therapeutics reprontherapeutics.com | Biotechnology Research | 1 | 2023 | Milan, Lombardy |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Repron Therapeutics
What does Repron Therapeutics do?
At Repron, we are developing an innovative strategy to inhibit the activity of oncogenes at the basis of tumor malignancy through the use of engineered synthetic factors. Oncogenic transcription factors activate thousands of target genes that, regulating processes like cell proliferation and invasiveness, make the cancer cells dangerous. By rational engineering of these factors, we exploit the natural binding ability to deliver repressive activity, instead of activation to their targets. Substituting the domain responsible for the activation with others featuring epigenetic inhibitory capabilities, we obtained Epigenetic Silencer Factors, that, once delivered in the cancer cells, are able to switch-off key genes for tumorigenesis. Our purpose is to provide solutions for those solid tumor cases in which the radical removal is not possible and metastasizing or recurrence is highly probable. Indeed, the delivery of Epigenetic Silencing Factors could intercept and eliminate either the remaining tumor cells at the primary site or the micro metastasis in target organs.
How many employees does Repron Therapeutics have?
Repron Therapeutics has around 1 employees on LinkedIn.
Where is Repron Therapeutics headquartered?
Repron Therapeutics is headquartered in Milan, Lombardy.
When was Repron Therapeutics founded?
Repron Therapeutics was founded in 2023.
Build a lead list from companies like Repron Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.